CONCURRENT STIMULATION OF CANNABINOID CB1 AND DOPAMINE D2 RECEPTORS AUGMENTS CAMP ACCUMULATION IN STRIATAL NEURONS - EVIDENCE FOR A G(S) LINKAGE TO THE CB1 RECEPTOR
M. Glass et Cc. Felder, CONCURRENT STIMULATION OF CANNABINOID CB1 AND DOPAMINE D2 RECEPTORS AUGMENTS CAMP ACCUMULATION IN STRIATAL NEURONS - EVIDENCE FOR A G(S) LINKAGE TO THE CB1 RECEPTOR, The Journal of neuroscience, 17(14), 1997, pp. 5327-5333
Cannabinoids act at the CB1 receptor to inhibit adenylate cyclase acti
vity via a pertussis toxin-sensitive G-protein. Within the striatum, C
B1 receptors have been shown to be localized on the same neurons as G(
i)-coupled dopamine D2 receptors. In this study we have examined the i
nteractions of CB1 and D2 receptors on adenylate cyclase. In striatal
neurons in primary culture, both the CB1 receptor agonist [3-(1,1 -dim
ethylheptyl)-11 -hydroxy-Delta(8)tetrahydrocannabinol] (HU210) and the
D2 receptor agonist quinpirole inhibited forskolin-stimulated cAMP ac
cumulation when applied separately. In contrast, HU210 and quinpirole
in combination augmented cAMP accumulation. This augmentation was bloc
ked by the CB1 receptor antagonist SR141716A or the D2 antagonist sulp
ride. Pertussis toxin treatment of striatal neurons prevented the inhi
bition of cAMP accumulation by D2 receptors but unmasked a cannabinoid
receptor-mediated stimulatory effect on cAMP accumulation. The cannab
inoid receptor-stimulated accumulation of cAMP was blocked in a concen
tration-dependent manner by SR141716A, suggesting that the response wa
s regulated through the CB1 receptor. Similar augmentation of cAMP acc
umulation after pertussis toxin treatment was observed in Chinese hams
ter ovary (CHO) cells transfected with, and stably expressing, the CB1
receptor. This stimulation of cAMP was not Ca2+-sensitive and was una
ffected by a range of protein kinase inhibitors. Treatment of the pert
ussis toxin-treated cells with cholera toxin before CB1 receptor activ
ation amplified the stimulatory pathway, suggesting that this response
was mediated through a G(s)-type G-protein. Stimulation of cAMP accum
ulation was not observed after pertussis toxin treatment of CHO cells
expressing the human CB2 receptor, suggesting that this novel signalin
g pathway is unique to the cannabinoid CB1 receptor.